[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354151-105":59,"doc-detail-354151-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","diagnostic-and-prognostic-significance-of-chemokines-in-head-and-neck-cancers-a-systematic-review-and-meta-analysis","Diagnostic and Prognostic Significance of Chemokines in Head and Neck Cancers - A Systematic Review and Meta-Analysis","","Head and neck cancers (HNCs) create a global health burden, with late-stage diagnosis and highly variable outcomes driving high morbidity and mortality. This systematic review and meta-analysis evaluates chemokines as diagnostic and prognostic biomarkers, aiming to improve early detection, risk stratification, and treatment decisions. Searches were conducted on 28 March 2026; 44 studies with 7294 participants were included. Results show MIP-3α linked to poorer survival, while IL-8 and CXCL10/CXCR4 show mixed associations. IL-8 in saliva supports oral squamous cell carcinoma detection, and Chemerin shows high but limited diagnostic accuracy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/diagnostic-and-prognostic-significance-of-chemokines-in-head-and-neck-cancers-a-systematic-review-and-meta-analysis/354151/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/diagnostic-and-prognostic-significance-of-chemokines-in-head-and-neck-cancers-a-systematic-review-and-meta-analysis/354151.png","ImageObject",300,407,{"name":92,"@type":93},"Chumphorn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does this systematic review address?","Question",{"text":112,"@type":113},"Whether chemokines can support diagnosis of head and neck cancers and whether they can estimate survival outcomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were studies identified for inclusion?",{"text":117,"@type":113},"A comprehensive literature search was conducted on 28 March 2026 across PubMed, Embase, Scopus, Web of Science, and EBSCO, with inclusion of observational studies evaluating chemokines in confirmed HNCs.",{"name":119,"@type":110,"acceptedAnswer":120},"Which chemokines showed the most consistent prognostic signals?",{"text":121,"@type":113},"MIP-3α demonstrated consistently significant associations with poorer survival outcomes, whereas IL-8, CXCL10, and CXCR4 showed inconsistent or largely non-significant associations across endpoints.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354151,1791503667,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336475401981,"https://ap-avatar.wpscdn.com/avatar/22000c94efd8d5204d?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786935347598174694","Systematic Review  \nDiagnostic and Prognostic Significance of Chemokines in Head and Neck Cancers: A Systematic Review and Meta-Analysis  \nRaneem Alsheikh 1, Deemah Assami 1, Dima Nasrallah 1, Ahmed Arabi 1, Ahmad Hamdan 1,2, Mohamed Ragab Elhadary 2, Ibrahim Elmakaty 2 and Mohammed Imad Malki 3, *  \nAcademic Editor: Orlando Guntinas-Lichius  \nReceived: 15 February 2026  \nRevised: 24 April 2026  \nAccepted: 28 April 2026  \nPublished: 30 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 College of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar;  \n[ra2104427@student.qu.edu.qa](ra2104427@student.qu.edu.qa) (R.A.); [da2106263@qu.edu.qa](da2106263@qu.edu.qa) (D.A.); [dn2105571@qu.edu.qa](dn2105571@qu.edu.qa) (D.N.)  \n2 Department of Medical Education, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar  \n3 Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar  \n* [Correspondence: momalki@qu.edu.qa](Correspondence: momalki@qu.edu.qa); Tel.: +974-4400-7874  \nSimple Summary  \nHead and neck cancers are a major cause of illness and death worldwide, largely because they are often diagnosed late and their clinical course can vary widely between patients. There is a growing need for reliable biological markers that can help doctors detect these cancers earlier and better predict patient outcomes. Chemokines are small signaling proteins that play an important role in inflammation and immune responses and may also influence cancer development and progression. In this study, we evaluated existing studies to understand whether chemokines can be used to support the diagnosis of head and neck cancers or to estimate survival outcomes. Our findings show that certain chemokines are strongly associated with poor prognosis, while others demonstrate potential value in cancer detection. This work highlights the clinical relevance of chemokines and supports further research into their use as diagnostic tools, prognostic markers, and possible therapeutic targets in head and neck cancers.  \nAbstract  \nBackground: Head and neck cancers (HNCs) represent a global health burden, with high morbidity and mortality largely driven by late-stage diagnosis and heterogeneous clinical outcomes. Reliable biomarkers are needed to improve early detection, prognostic stratification, and therapeutic decision-making. This study evaluates the diagnostic and prognostic value of chemokines in HNCs and identifies candidates with clinical relevance. Methods: A comprehensive literature search was conducted on 28 March 2026 across PubMed, Embase, Scopus, Web of Science, and EBSCO. Observational studies involving patients or biological samples with confirmed HNCs were included if they evaluated chemokines as diagnostic or prognostic biomarkers. Risk of bias was assessed using the Newcastle–Ottawa Scale (NOS) for prognostic studies and the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool for diagnostic studies. Meta-analyses were performed for chemokines evaluated in ≥3 studies using the inverse-variance heterogeneity model. Results: Forty-four studies encompassing 7294 participants were included. Prognostic findings were heterogeneous across biomarkers. MIP-3α demonstrated consistently significant associations with poorer survival outcomes. In contrast, IL-8, CXCL10, and CXCR4 showed inconsistent or predominantly non-significant associations with overall survival (OS), disease-free survival (DFS), and locoregional control (LRC) . For diagnostic performance, IL-8, in saliva, demonstrated relatively high sensitivity and specificity for oral squamous cell carcinoma. Chemerin showed high diagnostic accuracy, although evidence remains limited. Conclusions: Certain chemokines show potential as diagnostic and  \nprognostic bi","cbCaijAb3QpKKomB","https://ap.wps.com/l/cbCaijAb3QpKKomB","pdf",1738253,27,"English","# Abstract\n# Introduction\n## Clinical burden and diagnostic challenges\n## Role of chemokines in cancer biology\n# Methods\n## Literature search and inclusion criteria\n## Risk of bias and assessment tools\n## Meta-analysis approach\n# Results\n## Study characteristics\n## Prognostic associations\n## Diagnostic performance\n# Conclusions","[{\"question\":\"What question does this systematic review address?\",\"answer\":\"Whether chemokines can support diagnosis of head and neck cancers and whether they can estimate survival outcomes.\"},{\"question\":\"How were studies identified for inclusion?\",\"answer\":\"A comprehensive literature search was conducted on 28 March 2026 across PubMed, Embase, Scopus, Web of Science, and EBSCO, with inclusion of observational studies evaluating chemokines in confirmed HNCs.\"},{\"question\":\"Which chemokines showed the most consistent prognostic signals?\",\"answer\":\"MIP-3α demonstrated consistently significant associations with poorer survival outcomes, whereas IL-8, CXCL10, and CXCR4 showed inconsistent or largely non-significant associations across endpoints.\"}]","Diagnostic and Prognostic Significance of Chemokines in Head and Neck Cancers - A Systematic Review and Meta-Analysis | PDF",1790109237,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/592a64422714d0c5560ce44b5e98b4c0.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f2956d826bfb6b9f90b996cdf4c5913b.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce2cae12c765cd4bf53cf426bb00deaa.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5270aae023aa7e944b6e6b507452e84.webp",980,1385]